Aytu BioPharma, Inc. (AYTU)
After hours:
| Previous Close | 3.1800 |
| Open | 3.2200 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 3.1742 - 3.2700 |
| 52 Week Range | 1.3800 - 3.5000 |
| Volume | |
| Avg. Volume | 20,832 |
| Market Cap | 18.206M |
| Beta (5Y Monthly) | -1.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.0100 |
| Earnings Date | May 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.00 |
ACCESSWIREAytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
DENVER, CO / ACCESSWIRE / May 8, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its financial and operational results for its third quarter of ...
- ACCESSWIRE
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
Webcasted presentation to take place at 4:40 p.m. Eastern time DENVER, CO / ACCESSWIRE / April 3, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced ...
GlobeNewswirePresenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
